Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on for cognitive and negative symptoms in schizophrenia
NCT02001103Phase 3Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in schizophrenia, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02001103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001103.